First-of-its-Kind trial aims to wake up Brain-Injured patients
NCT ID NCT03814356
Summary
This early-phase study is testing whether intravenous methylphenidate (a stimulant) can safely help restore brain network connections in patients with severe disorders of consciousness, such as coma or vegetative state, following traumatic or anoxic brain injury. The trial will enroll 10 patients in intensive care to receive gradually increasing doses while closely monitoring safety and measuring brain activity changes via EEG and MRI. The main goal is to find the highest safe dose and see if the drug affects brain connectivity patterns that might support recovery of awareness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANOXIC BRAIN INJURY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.